Semaphorin 3Cesophageal squamous cell carcinoma (ESCC)Neoadjuvant immunotherapy
…te metabolism and elevated stemness, driving CAF activation via Semaphorin 3C secretion. Strikingly, this ‘LAMC2+ boundary tumor cell-immune-…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Semaphorin 3C ×
Semaphorin 3C
This drug is selected. Its supporting articles are shown below.